Ultragenyx Pharmaceutical Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Ultragenyx Pharmaceutical

Access the complete profile.

Ultragenyx Pharmaceutical Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	60, Leveroni Court Novato, CA 94949

Note: Revenues for privately held companies are statistical evaluations.


Ultragenyx Pharmaceutical's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Ultragenyx Pharmaceutical's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Ultragenyx Pharmaceutical is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Ultragenyx Pharmaceutical Annual Revenue and Growth Rate

Ultragenyx Pharmaceutical	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Ultragenyx Pharmaceutical's revenues are gauged from an analysis of company filings.

Ultragenyx Pharmaceutical's Income Statement (based on Industry Averages)

Ultragenyx Pharmaceutical P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Ultragenyx Pharmaceutical has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
December 31, 2012	34	100%	$75 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Ultragenyx Pharmaceutical is developing and marketing. Ultragenyx Pharmaceutical's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
GENGLYCOS Pharmaceutical preparations and substances for the treatment of metabolic and rare metabolic and genetic diseases and disorders; gene therapy products for the treatment of metabolic and rare diseases and disorders, namely, virus vector-based gene therapies for intravenous delivery	03/03/2023
IMGLYSTA Pharmaceutical preparations and substances for the treatment of metabolic and rare metabolic and genetic diseases and disorders; gene therapy products for the treatment of metabolic and rare diseases and disorders, namely, virus vector-based gene therapies for intravenous delivery	03/03/2023
GENREXVY Pharmaceutical preparations and substances for the treatment of metabolic and rare metabolic and genetic diseases and disorders; gene therapy products for the treatment of metabolic and rare diseases and disorders, namely, virus vector-based gene therapies for intravenous delivery	03/03/2023

See all trademarks and details in the Full Report.

Market Share of Ultragenyx Pharmaceutical's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ultragenyx Pharmaceutical, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Ultragenyx Pharmaceutical. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOMARIN PHARMACEUTICAL	San Rafael, CA	100
ULTRAGENYX PHARMACEUTICAL	Novato, CA	66
HAHNEMANN LABORATORIES	San Rafael, CA	1
MERCAPTOR DISCOVERIES	Novato, CA	0
KNEE JOINT	Mill Valley, CA	0
OPTISOMIX	Belvedere Tiburon, CA	0

Future Competition: Ultragenyx Pharmaceutical's Fastest Growing Competitors

These companies are in the same general field as Ultragenyx Pharmaceutical and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)